Stay updated with breaking news from Primary Endpoint. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ligand Pharmaceuticals Incorporated announced that its partner Viking Therapeutics, Inc. announced positive top-line results from its Phase 2b clinical trial of VOYAGE, a novel liver-selective thyroid... | May 17, 2023
Case 1:23-cv-02568-ER Document 19 Filed 05/04/23 Page 1 of 37 Plaintiff Esperion Therapeutics, Inc. , by its attorneys, Gibson, Dunn &... | May 4, 2023
- Drove 18% Quarterly Net Revenue Growth of COSELA® Over the Fourth Quarter of 2022; Grew Quarterly Vial Volume by 21% Over Prior Quarter - - Provided Updated Timing for Interim Overall Survival... | May 3, 2023
First-Quarter 2023 Results: -- Net Sales of $832.1 Million -- -- GAAP Net Income of $54.7 Million; Adjusted EBITDA of $232.9 Million -- -- TEPEZZA® Net Sales of $405.3 Million -- --... | May 3, 2023
-- At Week 24, patients treated with TEPEZZA achieved a 2.41 mm reduction in proptosis from baseline compared with 0.92 mm for those receiving placebo -- -- 62% of patients treated with TEPEZZA had... | April 10, 2023